← Back to front page
United States · Exchanges & live quotes · Nasdaq

Amgen vs. Gilead Sciences: Which Biotech Dividend Stock Is the Better Buy?

Published by Nasdaq · United States 3 h ago

Key PointsAmgen and Gilead pay forward dividend yields above 2%.

Read the full article on Nasdaq Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.nasdaq.com)

Also worth reading

OilPrice.com

Record Tanker Rates Cripple U.S. Crude Oil Flows to Asia

 CoinMarketCap

Worldcoin Drops 13% as Institution Moves 19.7M WLD

 Investopedia

Are You Earning More or Less Than Others Your Age? New Fed Data Reveals the Answer

 Cboe Global Markets

Tech Sell-Off Leads to Uptick in Defensive Stocks

 Google Finance

Introducing new self-learning context enrichment in Knowledge Catalog